Prinzide and Lortab drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prinzide (hydrochlorothiazide; lisinopril) and Lortab (acetaminophen; hydrocodone bitartrate). Common drug interactions include constipation among females and gait disturbance among males.

The phase IV clinical study analyzes what interactions people have when they take Prinzide and Lortab. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Prinzide?

Prinzide has active ingredients of hydrochlorothiazide; lisinopril. It is often used in high blood pressure. eHealthMe is studying from 2,218 Prinzide users. Check the latest studies of Prinzide.

What is Lortab?

Lortab has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 31,285 Lortab users. Check the latest studies of Lortab.



On Jul, 15, 2026

21 people who take Prinzide and Lortab together, and have interactions are studied.

Prinzide and Lortab drug interactions.

What are the common drug interactions of Prinzide and Lortab, by gender? *:

female:

  1. Constipation
  2. Depression
  3. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  4. Dizziness
  5. Dyspnoea (difficult or laboured respiration)
  6. Enthesopathy (disorder of entheses (bone attachments))
  7. Essential hypertension (primary hypertension)
  8. Fatigue (feeling of tiredness)
  9. Femur fracture
  10. Fibromyalgia (a long-term condition which causes pain all over the body)

male:

  1. Gait disturbance
  2. Memory impairment
  3. Drug ineffective
  4. Dysarthria (speech disorder)
  5. Fall
  6. Headache (pain in head)
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Injury
  9. Intervertebral disc degeneration (spinal disc degeneration)
  10. Intervertebral disc protrusion (spinal disc protrusion)

What are the common drug interactions of Prinzide and Lortab, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Nephrolithiasis (calculi in the kidneys)
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Thrombosis (formation of a blood clot inside a blood vessel)

40-49:

  1. Headache (pain in head)
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Ataxia (loss of full control of bodily movements)
  4. Balance disorder
  5. Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
  6. Cerebral atrophy (decrement in size of brain)
  7. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  8. Dizziness
  9. Drug hypersensitivity
  10. Dysarthria (speech disorder)

50-59:

  1. Vasculitis (inflammation of a blood vessel or blood vessels)
  2. Vision blurred
  3. Abdominal pain
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Dehydration (dryness resulting from the removal of water)
  6. Depressed level of consciousness
  7. Headache (pain in head)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Influenza
  10. Intervertebral disc degeneration (spinal disc degeneration)

60+:

  1. Drug ineffective
  2. Fall
  3. Cellulitis (infection under the skin)
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Chondropathy (disease of the cartilage)
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Coronary artery stenosis (narrowing of coronary artery)
  8. Drug hypersensitivity
  9. Epistaxis (bleed from the nose)
  10. Essential hypertension (primary hypertension)

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 3 people, 14.29%
  2. Multiple Myeloma (cancer of the plasma cells): 3 people, 14.29%
  3. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 9.52%
  4. Nausea (feeling of having an urge to vomit): 2 people, 9.52%
  5. Muscle Spasms (muscle contraction): 2 people, 9.52%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 9.52%
  7. Multiple Allergies (allergy to multiple agents): 2 people, 9.52%
  8. Hypertensive Heart Disease: 2 people, 9.52%
  9. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 9.52%
  10. Headache (pain in head): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Prinzide and Lortab?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Prinzide and Lortab:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prinzide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lortab:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prinzide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lortab and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydrochlorothiazide; lisinopril and acetaminophen; hydrocodone bitartrate (the active ingredients of Prinzide and Lortab, respectively), and Prinzide and Lortab (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: